Evidence map›Paper›PMID 41236625›Full record

ArticleExtremophiles : life under extreme conditions2025

hEDTA and EDDS as sustainable and harmless alternatives to NTA as trace metal chelators in Methanothermobacter marburgensis cultivation.

Fabian Schwarzmann, Elisa Hilts, Shubham Gurav, Franziska Steger, Simon K-M R Rittmann, Christian Fink

Abstract read
In one paragraph

Article in Extremophiles : life under extreme conditions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fabian SchwarzmannArkeon GmbH, Tulln a. d. Donau, Austria.
Elisa HiltsArkeon GmbH, Tulln a. d. Donau, Austria.
Shubham GuravACIB, Austrian Centre of Industrial Biotechnology, Vienna, Austria.
Franziska StegerArkeon GmbH, Tulln a. d. Donau, Austria.
Simon K-M R RittmannArkeon GmbH, Tulln a. d. Donau, Austria. simon.rittmann@univie.ac.at.ORCID http://orcid.org/0000-0002-9746-3284
Christian FinkArkeon GmbH, Tulln a. d. Donau, Austria. christian.fink@uni-tuebingen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The thermophilic methanogenic archaea Methanothermobacter spp. are applied as archaeal cell factories in industrial processes for methane production. Recently, secretion of commodity chemicals by M. marburgensis, such as amino acids, organic acids, or lipids has been observed. Together with the genetic tools available, genetically engineered cell factories for commodity chemical production from CO2 can be developed. However, the toxicity of the commonly used trace metal chelator Nitrilotriacetic acid (NTA) for M. marburgensis blocks potential regulatory approval for human applications. Therefore, we identified EDDS and hEDTA as suitable non-toxic alternatives as metal chelators for M. marburgensis. While EDDS reduces the specific growth rate (µ) of M. marburgensis by 40%, hEDTA shows the same µ as with NTA usage. Additionally, hEDTA offers cost wise a sustainable economic alternative to NTA with 23 € m− 3 of growth medium compared to 13 € m− 3 with NTA. With hEDTA as a harmless alternative to NTA, we are one step closer to industrial sustainable commodity chemical production from CO2 with M. marburgensis.

Indexed as

Chelating AgentsMethanobacteriaceaeNitrilotriacetic AcidChelating AgentsNitrilotriacetic AcidArchaeaBiotechnologyMethanogensMicrobiology

Identifiers

PMID41236625
PMCPMC12618441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.